Authors


David Grembowski, PhD

Latest:

Outcomes Among Chronically Ill Adults in a Medical Home Prototype

This study investigated healthcare quality, utilization, and costs among patients with common chronic illnesses in a patient-centered medical home prototype redesign.


Roy Pardee, JD, MA

Latest:

Primary Care Physician Resource Use Changes Associated With Feedback Reports

Implementing systemwide dissemination of feedback reports to primary care physicians in an integrated delivery system may be associated with changes in medical resource use.


Adan Z. Becerra, PhD

Latest:

Medicare Annual Wellness Visit Association With Healthcare Quality and Costs

In the context of 2 primary care physician–led accountable care organizations, Medicare Annual Wellness Visits were associated with lower healthcare costs and improved clinical care quality for beneficiaries.


Donna Dugan, PhD, MS

Latest:

Solutions for Filling Gaps in Accountable Care Measure Sets

Gaps in accountable care measure sets can be addressed efficiently using priority measure types and innovative approaches to measurement.



Jaime Davidson, MD

Latest:

Previously Unrecognized Trends in Diabetes Consumption Clusters in Medicare

Medicare beneficiaries with diabetes who are at the lowest levels of healthcare consumption often become some of the highest level consumers in subsequent years.


Jill Rubin Hummel, JD

Latest:

Impact of Medical Homes on Quality, Healthcare Utilization, and Costs

Patient-centered medical home practices provided better preventive care and disease management with less resource utilization than practices not pursuing PCMH status.



Rozalina G. McCoy, MD, MS

Latest:

Patient Attribution: Why the Method Matters

Reliable identification of the physician–patient relationship is necessary for accurate evaluation. Standardization of evidence-based attribution methods is essential to improve the value of healthcare.


Yonghua Jing, PhD

Latest:

Impact of Cost-Sharing on Treatment Augmentation in Patients With Depression

Higher patient cost-sharing is associated with a lower likelihood of treatment augmentation in patients with depression who are treated with antidepressants.


Bruce Feinberg, DO

Latest:

Better Together? Costs of First-line Chemoimmunotherapy for Advanced Non–Small Cell Lung Cancer

Compared with first-line immunotherapy or chemotherapy alone, combination chemoimmunotherapy for advanced/metastatic non–small cell lung cancer has significantly higher antineoplastic drug and associated medical costs.


William S. Weintraub, MD

Latest:

Impact of Care Coordination Based on Insurance and Zip Code

A care transitions program for patients who underwent percutaneous coronary intervention appeared to reduce 30-day rehospitalizations for patients with Medicaid who lived in wealthier zip codes.




Stuart C. Gordon, MD

Latest:

Late Diagnosis of Hepatitis C Virus Infection, 2014-2016: Continuing Missed Intervention Opportunities

Late hepatitis C virus infection diagnosis points to a need for earlier screening and treatment before the onset of severe liver disease leading to high cost and diminished outcomes.



Bevanne Bean-Mayberry, MD, MHS

Latest:

Organization of Care and Diagnosed Depression Among Women Veterans

This analysis studies effects of practice structures, primary care and mental health integration, and sex-specific primary care services on diagnosis of depression among women veterans.


Pamela Roberto, PhD

Latest:

Impact of Formulary Restrictions on Medication Intensification in Diabetes Treatment

Formulary restrictions on brand name noninsulin antihyperglycemic drugs have little impact on treatment intensification patterns among low-income patients with diabetes in Medicare Part D.



Andrea Hassol, MSPH

Latest:

Enhancing Patient and Family Engagement Through Meaningful Use Stage 3: Opportunities and Barriers to Implementation

Two leading US health systems attempted to implement 4 draft objectives for Meaningful Use Stage 3 within their health IT infrastructure to provide feedback on needed enhancements to the policy.


Judith Kutzleb, DNP

Latest:

Study: Health Recovery Solutions Uses Tablets to Reduce Cardiac Readmissions

Pilot program implemented at Hackensack ACO that provides hospitals and ACOs an early warning system to manage their highest risk patients.


Daniel A. Handel, MD, MBA, MPH

Latest:

Inpatient Placement: Associations With Mortality, Cost, and Length of Stay

Placement of patients in an inpatient hospital setting is associated with lower length of stay and mortality at the expense of higher costs.





Melinda B. Buntin, PhD

Latest:

Managed Care Reflections: A Q&A With Melinda B. Buntin, PhD

To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The June issue features a conversation with Melinda B. Buntin, PhD, a health economist and a Bloomberg Distinguished Professor at the Johns Hopkins Bloomberg School of Public Health and Carey Business School.



Allison B. Rosen, MD, MPH, ScD

Latest:

Patient Adherence: A Blind Spot in Cost-Effectiveness Analyses?

A systematic literature review from 1998 to 2003 showed that few cost-effectiveness analyses of self-administered medications model suboptimal medication adherence.



AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo